A total of 200 freshly voided goat faeces samples were collected in the study and were examined for the presence of thermophilic Campylobacter spp. The samples were obtained randomly from 2 farm settlements in Venda region, South Africa in 2008 to 2009. All samples were analyzed with the mCCDA media with Campylobacter supplement in microaerophilic condition provided by the Campygen gas envelope (Oxoid). Of the total 200 samples, the recovery rate was 29% (58 of 200) for all samples. Of the 200 samples, 155 (77.5%) were non-diarrheic and 45 (22.5%) were diarrheic faeces. From the 45 diarrheic faces, 41 (91.1%) were positive for campylobacters and of the 155 non-diarrheic faeces, 17 (11.1%) were positive for campylobacters. In all, 58 Campylobacter species comprising 33 (56.9%) Campylobacter jejuni and 8 (13.9%) Campylobacter coli strains were from diarrheic and 2 (3.4%) C. jejuni and 15 (25.9%) C. coli were from non-diarrheic faeces. There was no statistical correlation between the incidence of C. jejuni in diarrheic faeces and non-diarrheic faeces. Rate of resistance of C. jejuni and C. coli to six regularly used antibiotics in human and veterinary campylobacteriosis; ciprofloxacin, gentamycin, ampicillin, tetracycline, nalidixic acid and erythromycin were 40. 0, 47.1%, 57.1, 43.5%, 48.6, 56.5%, 42.9,  43.5%, 34.3, 34.5% and 14.3, 17.4%, respectively . In comparison, a significantly higher frequency of resistance to gentamycin was recorded among the C. jejuni and C. coli isolates (57.1 versus 43.5%) respectively, at p < 0.005 from goats in all farms. Resistance to ciprofloxacin and kanamycin was higher among the C. coli than C. jejuni strains but the difference was not statistically significant. Comparable occurrences of resistance were observed among C. jejuni and C. coli to erythromycin and nalidixic acid. High prevalence of thermophilic Campylobacter spp. in goat could be of public health significance in the Venda region. The observed multi-drug resistance and especially resistance to macrolides and fluoroquinolones in this study pose a threat of transfer of antibiotic resistance to human pathogens because of the close contact between goats and man.
INTRODUCTION
During the past decade, Campylobacter jejuni has been recognized as a major cause of human gastroenteritis. In several developed countries the incidence of campylobacteriosis exceeds that of salmonellosis (Foster, 1986; Skirrow, 1990) . In the Netherlands, sentinel *Corresponding author. E-mail: uaboiegbenni@yahoo.com. studies revealed that campylobacteriosis accounts for approximately 12% of all the cases of acute human gastroenteritis (Hoogenboom-Verdegaal et al., 1989) . Foods of animal origin may serve as vehicles of infection (Blaser et al., 1984) . In many reports, an asso-ciation has been made between campylobacteriosis and recent consumption of raw or undercooked poultry meat (El-Shenawy and Marth, 1989; Oosterom et al., 1984) . Up till now, however, the pathways involved in the infection of poultry flocks are still unclear. Several factors suspected to be sources or vectors of infection have been the subjects of studies. Kazwala et al. (1990) suggested that, flocks were most likely infected from the environment of the poultry houses.
In Nigeria, small ruminants (sheep and goats) constitute about 35% of the total meat supply (FAO, 1995; Salihu et al., 2009) . Sheep and goats have played very important role in offsetting the protein deficiencies which are fairly rampant in the country. There is a growing appreciation of the importance of goats in small-scale integrated farming system in developing countries (Devendra and Mcleroy, 1992) . In most developing countries, goats with cattle, sheep and poultry with very poor veterinary inputs and hygiene are reared. The husbandry systems under which goats are reared in Sokoto, Nigeria, bring them in close contact with humans and other animals including dogs and cats (Salihu et al., 2009) . This system of rearing is a common practice in developing countries especially in African countries where animal rearing is a common source of protein and income. Campylobacters have been reported among healthy and diseased farm animals in Nigeria and Tanzania (Olubunmi and Adeniran, 1986; Jiwa et al., 1994; . It has also been reported in raw milk, goats and cattle in Europe and several other countries (Oporto et al., 2009; Anderson et al., 2006; Baserisalehi et al., 2007; Suzuki and Yamamoto, 2009 ). Salihu et al. (2009) in their study in Sokoto, Nigeria, noted that 20% of the goat faecal droppings contain Campylobacter spp. A prevalence study recently carried out in the Basque country (Northern Spain) identified 28.3% (34/120) of ovine and 18.0% (37/206) of bovine farms positive for C. jejuni (Oporto et al., 2007) and even higher values (38.2%, 13/34) in free-range poultry farms (Esteban et al., 2008) . The natural habitat of most Campylobacter spp. is the intestine of birds and other warm-blooded animals, including seagulls and several other wild birds (Kapperud and Rosef, 1983) . Campylobacteriosis is primarily a food-borne disease, because of its low infective dose, it has been estimated that 500 cells of C. jejuni can cause human illness (Black et al., 1988) . From this, it is clear that even small number of Campylobacter cells in water or food due to faecal contamination may be a potential health hazard (Salihu et al., 2009) .
Sporadic abortion due to campylobacteriosis has been reported in sheep and goats although goats are known to be more resistant to Campylobacter infections resulting in fewer abortions (Moeller, 2009) . The three species of Campylobacter adjudged to cause abortion are Campylobacter fetus, C. jejuni and Campylobacter lari. Campylobacter infections most often cause late term abortions, stillbirths, or the birth of weak non-viable lambs/ewe (Moeller, 2009) .
Recently, the concern for this foodborne infection has increased because of the frequent isolation of antimicrobial resistant strains in humans and animals (Aarestrup and Wegener, 1999) . This is a consequence Uaboi-Egbenni et al. 14117 of the massive use of antibiotics in modern intensive animal production for therapy and prevention of diseases, as well as use of same as growth promoters. Hence, food animal origin may represent a vehicle of transmission of resistant Campylobacter spp. to humans. This applies particularly for strains resistant to quinolones and erythromycin, widely used for therapy in human systemic infections or in severe long-lasting cases of enteritis (Aarestrup and Engberg, 2001; Pezzotti et al., 2003) . However, there was stability pattern in resistance between 1997 and 2001 with a value of 2%. Bywater et al. (2004) in their study of incidence of Campylobacter in chicken, cattle and pig and their antimicrobial resistance, observed differential resistance to ciprofloxacin of Campylobacter coli and C. jejuni isolated from chicken with a prevalence of 39.6 to 14.9%, respectively. In all the tests, they observed higher resistance of C. coli over C. jejuni to nalidixic acid (39.6, 15.1%), erythromycin (13.6, 1.0%) and tetracycline (58.4, 35.4%). The trend was the same for all the isolates from cattle and pig with C. coli showing higher resistance to the aforementioned antibiotics. Pezzotti et al. (2003) in their study of chicken and pork meat noted higher resistance of isolated C. coli and C. jejuni to ten selected antibiotics. Percentage of resistance of chicken isolates was 78.6 and 52.8 for enfloxacin, 78.5 and 52.8 for ciprofloxacin, 78.6 and 59.7 for nalidixic acid, 48.2 and 31.9 for tetracycline, 25.0 and 12.5 for erythromycin, and 30.4 and 5.6 for streptomycin. For pork meat, resistance trend were similar with C. coli showing more resistance to the antibiotics than C. jejuni, with exception of gentamycin, where C. jejuni resistance was 1.4% and all C. coli isolates were susceptible. The risk factors associated with the infection include occupational exposure to farm animals, consumption of raw milk or milk products and unhygienic food preparation practices (Alterkruse et al., 1999) . It has been reported that difficulty in Campylobacter detection is responsible for deficiency in the accurate information concerning Campylobacter infection in developing countries (Baserisalehi et al., 2006 (Baserisalehi et al., , 2007 , but Campylobacter is hyper-endemic in developing countries (Salihu et al., 2009 ). Added to this, is the fact that there is lack of surveillance and database relating to prevalence of Campylobacter organisms in developing countries. While the incidence and prevalence of campylobacters have been reported extensively in developed nations among other animals, there is a dearth of information on the shedding patterns of Campylobacter spp. by goats in developing nations, South Africa inclusive. This study was intended to determine the prevalence, pathological indices and antibiotic susceptibility profiles of Campylobacter species among goats in two farm settlements in Venda region, South Africa.
MATERIALS AND METHODS

Description of the farm settlements
The farm settlements were separated from each other by about 80 Km and apart from goats other farm animals co-reared were cattle, sheep and chicken. The farms were each located about 500 m from the stream from which the animals drink water and which also serve as water supply for the community. Hence, runoffs after heavy rainfall are capable of contaminating this surface water that serve as source of drinking water for the community and may result in an epidemic situation.
Sample collection
A total of 200 faecal samples were collected from apparently healthy and observed diarrheagenic goats from two farm settlements named X and Y for ethical reasons from the Venda region in the Limpopo province, South Africa, over a period of six months. Freshly voided faeces were collected aseptically in sterile collection tubes, refrigerated in cooler packed with ice and were transported to the laboratory within 1 h of collection. The samples were inoculated directly on mCCDA to which the selective supplement had been added and incubated at 42°C for 48 h under microaerophilic condition using Campygen (Oxoid, CM739, SR 155E, CM 025) (Oxoid Ltd, Basingstoke, RG24 8PW, U.K). This temperature was used for the specific isolation of thermophilic pathogenic Campylobacter species. From the positive agar plates, 2 to 3 colonies showing typical Campylobacter features were selected and subcultured and thereafter, were tested for gram-staining, motility, production of oxidase and catalase. These isolates were stored in brain heart infusion agar (BHA) with 15% (V/V) glycerol at -20°C prior to further characterization. Agglutination tests using Campylobacter dryspot (specific for thermophilic Campylobacter species and Mast diagnostic test (specific for C. jejuni, C. coli and C. lari) were done according to the manufacturer's instruction. The dryspot Campylobacter test kit (agglutination test for pathogenic Campylobacter strains of C. jejuni, C. coli, Campylobacter upsaliensis and C. lari) was used in conjunction with Mast diagnostic method which incorporates biochemical tests involving test for hippurate hydrolysis, indoxyl acetate hydrolysis and urea hydrolysis through the urease system. The Oxoid agglutination and Mast tests were done according to the manufacturer's instruction. Agglutination under normal lighting condition is indicative of Campylobacter and belongs to any of the four species mentioned earlier (Baker et al., 2006; Chaban et al., 2010) . The result from the Mast tests enables speciation of the Campylobacters isolates. The number of faeces samples (diarrheic and non-diarrheic) positive for Campylobacter and the number of C. jejuni and C. coli is shown in Table 1 .
PCR confirmation of Campylobacter
Genomic DNA was obtained by the whole-cell lysate method as described by Marshall et al. (1999) . In order to ascertain if the dryspot/Mast diagnostic kit positive Campylobacter isolates were actually campylobacters, they were subjected to PCR identification using the general primers for the identification of campylobacteria. However, Arcobacter and Helicobacter spp. showed negative reaction to the Campylobacter dryspot kit. Hence, any amplification of the primer sequences at the 1,004 bp fragment within the coding region of 16S rRNA confirmed that, such isolates are Campylobacter spp. and not Helicobacter or Arcobacter spp. Oligonucleotides primers employed in this study were CAH16S 1a (5' -AAT ACA TCA AAG TCG AAC GA -3') and CAH16S 1b (TTA ACC CAA CAT CTG ACG AC -3'), respectively. The oligonucleotides used in this study were synthesized by Inqaba Biotechnologies (Pretoria, South Africa). The micrograph of the PCR products of the 16S rRNA is shown in Figure 1 .
Haemolysis test
To ascertain the pathogenic status of the isolates, the Campylobacter spp. was subjected to haemolytic test according to the procedure of Samie et al. (2006) . Briefly, a 24 h broth culture of Campylobacter spp. was cultured by spread plate method on Columbia agar supplemented with sheep blood. Plates were incubated at 35°C for 24 h.
Thereafter, plates were observed for complete haemolysis and partial haemolysis. The haemolytic profile is shown in Table 2 .
Antibiotic susceptibility studies
Antimicrobial agents
The antibiotics tested in this study were: trimethroprim (2.5 µg), nalidixic acid (30 µg), ciprofloxacin (5 µg), gentamycin (10 µg), tetracycline (30 µg), ampicillin (10 µg), erythromycin (15 µg), streptomycin (10 µg), methicillin (µg), cefexime (30 µg), imipenem (µg), kanamycin (30 µg) and vancomycin (30 µg) (Oxoid, Unipath Ltd, Basingstoke, England). However, attention was paid more to the relevant antibiotics used for human and veterinary campylobacteriosis, since these antibiotics are used in cases of campylobacteriosis in humans. Some tetracycline is used as growth promoters in veterinary. 
Antimicrobial susceptibility testing
The method of Gaudreau and Gilbert (1997) was used. Briefly, the confirmed Campylobacter isolates were inoculated into plates of Mueller-Hinton agar plates carrying a minimum of five discs. All plates were incubated at 35°C under a microaerophilic atmosphere obtained with a gas generator envelope (Oxoid), for 24 h. The resulting zone diameters were measured with a graduated metre rule. Analysis of diameter was done according to the procedural methods of CLSI (2010) for enterobacteriaceae.
RESULTS
Two hundred (200) freshly voided goat faeces samples were analyzed in the study. The rate of recovery of Campylobacter was 29.0% (58 of 200) for all the cases. Of these, 91.1% (41 of 45) were from diarrheic and 11.1% (17 of 155) were from non-diarrheic faecal samples. Overall, 58 Campylobacter species comprising of 33 (56.9%) C. jejuni and 8 (13.9%) C. coli strains were isolated from diarrheic and 2 (3.4%) C. jejuni and 15 (25.9%) C. coli strains were isolated from non-diarrheic faeces (Table 1) . There was a higher prevalence of C. jejuni in diarrheic faeces than C. coli and vice versa. The high incidence rate of C. jejuni in diarrheic faeces is an indication that the campylobacteriosis witnessed among the goats in these farms had their origin from C. jejuni infection. This could lead to abortion and stillbirth among goats and a substantial economic loss to the rearers. There was a high incidence of C. coli compared with C. jejuni in the non-diarrheic faeces; a result that confirmed that the diarrhea noticed in the goats may have been caused by C. jejuni.
Haemolytic activity
Out of the 58 Campylobacter isolates tested for haemolysis, 55 (94.85) were -haemolytic and 3 (5.1%) were -haemolytic. None of the isolates was nonhaemolytic (Table 1) .
PCR results
The PCR studies of the 16S rRNA fragment of Campylobacter DNA showed that the DNA fragment was aligned at 1004 bp (Figure 1 ). Antimicrobial susceptibility Figure 2 shows the sensitive, intermediate and resistance profile of the 58 Campylobacter isolates exposed to six antibiotics employed in veterinary and human campylobacteriosis according to CLSI (2010) guidelines. The strains were more sensitive to erythromycin (macrolide) than the rest antimicrobials and were more resistant to gentamycin and ampicillin. On the basis of species resistance, C. coli isolates were more resistant to the six antibiotics. Individually, there was a high rate of resistance to some or all of the antibiotics. The rate of resistance of C. jejuni and C. coli to these antibiotics; ciprofloxacin, gentamycin, ampicillin, tetracycline, nalidixic acid and erythromycin were (40.0, 47.1%), (54.3, 60.9%), (57.1, 43.5%), (48.6, 56.5%), (42.9, 43.5%), (34.3, 34.5%) and (14.3, 17.4%), respectively. In comparison, a significantly higher frequency of resistance to gentamycin was recorded among C. jejuni and C. coli isolates (57.1 versus 43.5%), respectively, at p < 0.005 from goats in all the farms (Table 2) . Similarly, resistance to ciprofloxacin was higher among C. coli and C. jejuni isolates from goats but was not statistically significant (P > 0.005). For erythromycin and nalidixic acid, comparable occurrences of resistance were recorded among C. jejuni and C. coli from all the farms. C. coli isolates had a higher rate of resistance to ampicillin (56.5%) than C. jejuni (48.6%). Multiple resistances were shown to combination of antibiotics by Campylobacter isolates from all the farms. For example, 5 (14.3%) C. jejuni were resistant to all the six antibiotics, while 8 (34.8%) C. coli were also resistant to all the six antibiotics. The rate of multiple resistances among the different Campylobacter spp is shown in Table 3 . The multiple resistances witnessed in this study to the antibiotics is of public health significance as these multiple antibiotic resistant strains are capable of being disseminated into the wider environment to constitute source of acquisition of antibiotic resistant genes to other pathogens.
DISCUSSION
In this study, 29% (58 out of 200 animals) of the goats sampled were found to harbor Campylobacter isolates in their faeces. In a study done in Sokoto State, Nigeria, on 1312 faecal samples, over a period of 2 years, Salihu et al. (2009) found 20% of the faecal samples to be positive for Campylobacter. This presence and high prevalence of Campylobacter in goat is of serious concern in view of the high rate of consumption of goat meat in most African countries. This prevalence value is low when compared with reported prevalence rates in other food animal by several workers (Stanley and Jones, 2003; Sato et al., 2004; Workman et al., 2005; Verma et al., 2005; Baserisalehi et al., 2007; Uaboi-Egbenni et al., 2008) . Few available studies have reported heavy shedding of Campylobacter among goats (Salihu et al., 2009) . In this study, most Campylobacters isolated were from diarrheic faeces, although, few mainly C. coli and C. jejuni were also isolated from non-diarrheic faeces. More C. jejuni (60.4%) were isolated than C. coli (39.6%). This observation is in line with the report of Salihu et al. (2009) in Nigeria. However, the studies done in northern Nigeria on sheep showed a high prevalence of C. coli than C. jejuni. Although, there is paucity of reports on campylobacteriosis in goats, similar work done on other food animals have indicated enteritis and stillbirth in sheep (Dennis, 1990; Koides, 1991; , new born calves (Padungton and Kareene (2003) . Bywater et al. (2004) reported high prevalence of Campylobacter among chicken in France and UK (50 and 70%), in cattle in Germany and UK (66 and 50%) and pigs in France, Spain and UK (50, 42 and 35%). These variations in prevalence rate from one country to another shows discrepancies in the prevalence of Campylobacter spp. among different animals and may be a reflection of geographic factors and/or differences in strategies to monitor antibiotic use in different countries. Kimberly (1988) reported Jenson and Swiff's diseases of sheep in Philadelphia, LA, USA, resulting from campylobacteriosis caused by C. jejuni and its pathogenic allies. While disease conditions resulting from Campylobacter infections have been well studied in other farm animals, the nature of disease conditions in goats is still shrouded in obscurity.
Campylobacter have also been described in goat meat. In a recent study in Iran, the highest prevalent of Campylobacter spp was found in lamb meat (12.0%), followed by goat meat (9.4%), beef meat (2.4%) and camel meat (0.9%) (Rahimi et al., 2010) .
Studies of pathological indices of the Campylobacter isolates revealed that of the 58 Campylobacter isolates, 55 (94.8%) were -haemolytic, while 3 (5.2%) werehaemolytic. This finding support the studies of Samie et al. (2007) in Vhembe district on HIV/AIDS patients where they observed a high prevalence of -haemolytic C. jejuni. These animals may have served as source of infection of human population via contamination of surface and subsurface bodies of water in the Vhembe region.
Resistance to fluoroquinolones and macrolides has shown a tremendous increase over the past two decades (Saenz et al., 1997; Prats et al., 2000; Reina et al., 1994) . Quinolone resistance and to a lesser extent, macrolide resistance of Campylobacter isolates from the production of animals are now recognized as emerging public health problems (Engberg et al., 2001; Châtre et al., 2010; Smith and Fratamico, 2010) . Result from recent susceptibility studies of C. jejuni and C. coli from poultry meat performed in different countries indicated substantial variations between countries. Relatively high resistance rates in C. jejuni strains isolated from chicken meat were reported from Belgium (Van Looveren et al., 2001; Habib et al., 2009) , United States (Ge et al., 2003) and Italy (Pezzotti et al., 2003; Rollo et al., 2010) , moderates were reported from Switzerland (Ledergerber et al., 2003; Korczak et al., 2009 ) and northern Ireland (Wilson, 2003) , whereas, limited occurrences of antimicrobial resistance among C. jejuni was reported from Sweden (Lindmark et al., 2004) . A possible explanation for these differences might be that, occurrences of antimicrobial resistance are reflecting the different national and regional policies in relation to the use of antimicrobial agents for food animals. Although, there is a paucity of information on the antimicrobial susceptibility of Campylobacter isolates from goats on antibiotics to make effective comparison, various studies are available on the susceptibility profiles of Campylobacter isolates from other food animals and small ruminants.
Resistance of C. jejuni and C. coli to ciprofloxacin, tetracycline, nalidixic acid and erythromycin antibiotics in several food animals have been reported by other workers: cattle, sheep and poultry faeces (de Jong et al., 2009; Oporto et al., 2009; 2007; Sahin et al., 2008; Zweifel et al., 2004; Englen et al., 2005; EFSA, 2007) , in swine (Oporto et al., 2007) and from poultry farms (Esteban et al., 2008) . The resistance shown by Campylobacter isolates from goats to functional antibiotics used for human and veterinary campylobacteriosis has high public health significance. It brings to question if man has actually been able to unrivalled the various sources of antimicrobial resistance in animals and in the environment. The occurrence of high resistance to antibiotics among Campylobacter isolates from goats in this study need further investigation more so as no report on antibiotic susceptibility profile from goats has hitherto been reported.
In this study, we found significant difference in tetracycline resistance between C. jejuni and C. coli isolates. This observation is in line with the findings of Ge et al. (2003) who found that Campylobacter isolated from turkey meat showed high resistance than those from chicken meat. Similarly, Oporto et al. (2009) in their study, observed significantly high resistance of
Campylobacter isolated from sheep to those isolated from beef cattle and poultry but less significant value among those isolated from sheep and those from dairy cattle. Gibreel and Taylor (2006) in their review reported varied rates of resistances of C. jejuni and C. coli to erythromycin among human isolates in several countries. A high prevalence of resistance to most of the antibiotics was observed among C. coli isolates than C. jejuni isolates. Gibreel and Taylor (2006) observed a high prevalence of resistance among C. coli than C. jejuni isolated from cattle and pigs to tetracycline, ciprofloxacin and nalidixic acid. Similarly, these workers reported higher prevalence among C. coli than C. jejuni isolates from pigs and chicken to erythromycin, but higher prevalence of resistance in C. jejuni than C. coli isolates from cattle to erythromycin. They did not observe resistance to gentamycin in all their isolates except for 0.7% observed with C. jejuni and 0% for C. coli from cattle. In this study, the most stable antibiotic to the campylobacters isolated from goats in all the farms was erythromycin. This finding is in line with the observation of Bywater et al. (2004) who reported as low as between 1 to 2% resistance of Campylobacter spp. isolated from chicken, cattle and pigs.
The high prevalence of resistance to nalidixic acid, ciprofloxacin and tetracycline of Campylobacter spp. isolated from goats could be of public health importance. This is so, because a number of investigations from the United States, Thailand and Denmark have shown that infections with macrolide-resistant Campylobacter isolates could be associated with an increased risk of adverse events, development of invasive illness or death compared with infections with drug susceptible isolates (Travers and Barza, 2002; Helms et al., 2005) . The root of entry of the antibiotic-resistant campylobacters to goats has not been elucidated. Speculatively, the pastures on which these animals graze as well as surface waters from which they drink are likely sources of acquisition of these resistant strains of these campylobacteria. The isolation of fluoroquinolone, quinolone and macrolide-resistant Campylobacter species in goats has again stressed the need for proper surveillance of the use of antibiotics not only as growth promoters but as therapeutic use in veterinary medicine. There is also the need to monitor the emergence of resistant strains in order to develop new and effective antibiotics against campylobacteriosis. This will further protect man from acquisition of antibioticresistant Campylobacter strains from goat and the wider environment.
Conclusions
The study reported relatively high prevalence of Campylobacter species among goats in farms in South Africa. We also reported the isolation of Campylobacter species more from diarrheic than non-diarrheic faeces. C. jejuni was more commonly isolated when compared with C. coli. This study indicated that, goats can act as source of human infections as well as contamination of the wider environment. The isolation of fluoroquinolone, quinolone and macrolide-resistant Campylobacter species in goats has again stressed the need for proper surveillance of the use of antibiotics not only as growth promoter but as therapeutic use in veterinary medicine. There is also the need to monitor the emergence of resistant strains in order to develop new and effective antibiotics against campylobacteriosis. This will further protect man from the acquisition of antibiotic-resistant Campylobacter strains from goat and the wider environment. The dissemination of these Campylobacter organisms in faeces could result in an epidemic, if concerted efforts are not made to address the origin and cause of the observed prevalence. Excreted faeces when passed into the bodies of water and pastures could spread to other animals and humans that use such water as source of water supply for drinking. Based on the location of the farms (close to community stream) and coupled with the fact that other animals are reared together, we would have on our hand an epidemic situation which may be difficult to curtail if effective surveillance is not undertaken timely.
